未名医药 (002581.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(未名医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 103,928,259.06126,977,221.1783,804,783.2991,443,794.81129,180,025.24133,563,782.4275,602,502.59
 营业收入(元) 103,928,259.06126,977,221.1783,804,783.2991,443,794.81129,180,025.24133,563,782.4275,602,502.59
二、营业总成本(元) 112,231,775.76129,603,971.33106,361,412.35180,401,212.18146,627,573.86179,152,267.81104,535,537.78
 营业成本(元) 21,405,097.2424,133,429.2116,649,506.5419,641,323.2923,878,845.4625,292,519.0114,582,127.66
 研发费用(元) 5,758,374.875,795,403.246,208,293.7721,097,316.729,957,737.5720,416,075.178,327,976.44
 营业税金及附加(元) 1,614,789.301,721,213.911,549,826.381,774,911.811,767,691.362,380,067.58966,548.65
 销售费用(元) 62,509,573.3481,341,887.6346,805,847.2074,882,203.1977,053,676.2386,571,136.5749,790,563.52
 管理费用(元) 21,649,857.6617,136,612.5135,425,326.4162,989,992.0031,900,582.2842,132,044.4827,980,380.30
 财务费用(元) -705,916.65-524,575.17-277,387.9515,465.172,069,040.962,360,425.002,887,941.21
 资产减值损失(元) --424,227.83-295,116,507.19---
 信用减值损失(元) 2,502,617.69-372,394.841,457,482.4616,719,975.5862,143.30696,279.55262,988.02
三、其他经营收益
 加:投资收益(元) 55,992,891.769,709,559.66-6,740,217.6428,584,800.44108,016,122.8529,458,014.946,622,813.82
 资产处置收益(元) 835,511.93-3,327,245.52-814,394.58222,353.92-866,505.38-5,973,551.42291,408.45
 其他收益(元) 207,947.08307,744.63281,691.02570,428.875,317,536.64428,639.39609,761.88
四、营业利润(元) 51,235,451.763,690,913.77-27,947,839.97-337,976,365.7595,081,748.79-29,310,516.82-21,146,063.02
 加:营业外收入(元) 210,478.7267,621.811,662,922.08182,757.1731,000.03-16,237.7330,593.43
 减:营业外支出(元) 382,268.54230,702.93562,128.0018,142,628.271,008,532.10635,774.06339,933.07
五、利润总额(元) 51,063,661.943,527,832.65-26,847,045.89-355,936,236.8594,104,216.72-29,962,528.61-21,455,402.66
 减:所得税费用(元) 2,247,187.511,287,132.26208,294.924,727,379.994,722,531.37-488,446.43-76,304.06
六、净利润(元) 48,816,474.432,240,700.39-27,055,340.81-360,663,616.8489,381,685.35-29,474,082.18-21,379,098.60
(一)按经营持续性分类
  持续经营净利润(元) 48,816,474.432,240,700.39-27,055,340.81-360,663,616.8489,381,685.35-29,474,082.18-21,379,098.60
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 44,241,185.37-1,910,835.92-27,704,081.15-362,171,633.5483,470,619.53-32,251,312.42-21,505,965.06
  少数股东损益(元) 4,575,289.064,151,536.31648,740.341,508,016.705,911,065.822,777,230.24126,866.46
 扣除非经常性损益后的净利润(元) 43,563,933.571,336,593.56-28,329,965.37-350,072,169.1580,648,883.06-26,043,941.64-22,097,795.75
七、每股收益
 一、基本每股收益(元) 0.07--0.04-0.550.13-0.05-0.03
 二、稀释每股收益(元) 0.07--0.04-0.550.13-0.05-0.03
九、综合收益总额(元) 48,816,474.432,240,700.39-27,055,340.81-360,663,616.8489,381,685.35-29,474,082.18-21,379,098.60
 归属于母公司所有者的综合收益总额(元) 44,241,185.37-1,910,835.92-27,704,081.15-362,171,633.5483,470,619.53-32,251,312.42-21,505,965.06
 归属于少数股东的综合收益总额(元) 4,575,289.064,151,536.31648,740.341,508,016.705,911,065.822,777,230.24126,866.46
公告日期 2024-10-302024-08-282024-04-302024-04-302023-10-312023-08-312023-04-27
审计意见(境内) 保留意见

前瞻产业研究院